Joseph A. Sparano, MD, who recently gave a talk during the 19th Annual School of Breast Oncology, discusses prolonging responses to therapy in patients with advanced breast cancer.
Joseph A. Sparano, MD
Advertisement
Articles by Joseph A. Sparano, MD
Joseph A. Sparano, MD, discusses how identifying the risk of recurrence in patients with breast cancer can help inform treatment decisions.
Advertisement
Latest Updated Articles
Determining Risk of Recurrence in Patients With Breast Cancer Could Inform Treatment DecisionsPublished: December 11th 2020 | Updated:
The Evolution of Endocrine Therapy in Breast CancerPublished: September 14th 2016 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
